BCAX
#2302
Bicara Therapeutics Inc. - Common Stock
17.2 6 USD
+0.05%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+5.12%
Variación mensual
-25.95%
Variación en los últimos 6 meses
-21.55%
Cambio anual
+19.53%
Cierres anteriores
16.4 2
Open
16.3 2
Mínimo
15.8 5
Máximo
17.3 3
Financials
- Market Capitalization 1.14 B
- Employee 103
- Founded 2018
- CEO N/A
- Website www.bicara.com
- Headquarter Delaware, United States
- FIGI BBG00Z15DGK7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2265 |  REPL Replimune Group, Inc. - Common Stock | 13.04 USD | -1.21% | -4.75% | -9.88% | +179.83% | 1.23 B USD | ||
| 2277 |  TYRA Tyra Biosciences, Inc. - Common Stock | 19.97 USD | -2.06% | -6.02% | -6.73% | +39.26% | 1.19 B USD | ||
| 2310 |  VOR Vor Biopharma Inc. - Common Stock | 19.13 USD | +1.86% | +5.75% | -16.68% | +46.03% | 1.13 B USD | ||
| 2311 |  JANX Janux Therapeutics, Inc. - Common Stock | 18.50 USD | +3.24% | +7.25% | -3.50% | -29.31% | 1.13 B USD |